Newsletter

Pompe Disease
With one marketed therapy, and several in pipeline, Pompe disease market is anticipated to boost in the coming decade
Pompe Disease Newsletter

More Whitepapers / Newsletters

Primary Progressive Aphasia Market
Primary Progressive Aphasia (P...

Primary Progressive Aphasia (PPA) is a rare neurological disorder that results from the damages to the areas of brain responsible for communication (language and speech). Affected patients experience...

Osteosarcoma Market
Osteosarcoma

Osteosarcoma is a kind of bone cancer that originates from the cells that form bones. It is often found in the long bones more frequently in the legs than in the arms; however, it can start from anywh...

Systemic Lupus Erythematosus Market
Systemic Lupus Erythematosus (...

Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease that results in systemic inflammation as body’s immune system starts fighting against own’s healthy tissues and organs. It affects mu...

Rethinking medtech in Covid times
Rethinking medtech in Covid ti...

COVID-19 transforms healthcare facets at an unprecedented pace. Based on emerging technology, we can be reasonably sure that the bulk of the change will be powered by the digital transformation made p...

Herpes Zoster Oticus
Herpes Zoster Oticus

Herpes zoster oticus (HZ oticus) is a viral infection of the inner, middle, and external ear. A result of reactivation of varicella-zoster virus infection, it manifests as severe otalgia and associate...